Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand

QR Code

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand

Sermsiri Sangroongruangsri,1 Usa Chaikledkaew,1,2 Prut Hanusaha,3 Tanapat Ratanapakorn,4 Paisan Ruamviboonsuk5 1Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Mahidol University Health Technology Assessment (MUHTA) Gr...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sangroongruangsri S, Chaikledkaew U, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	pcv verteporfin anti-vegf agent retinal disease economic evaluation thailand Medicine (General) R5-920 Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/67b022bcc6ad4fccbb614ba25aaf8fef
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
par: Takahashi K, et autres
Publié: (2018)

Survey of Intravitreal Injection Techniques Among Retina Specialists in Mexico
par: Henaine-Berra A, et autres
Publié: (2020)

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
par: Ratanasukon M, et autres
Publié: (2018)

Choroidal excavation with polypoidal choroidal vasculopathy: a case report
par: Kobayashi W, et autres
Publié: (2012)

Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
par: Matsuo Y, et autres
Publié: (2021)

Major single nucleotide polymorphisms in polypoidal choroidal vasculopathy: a comparative analysis between Thai and other Asian populations
par: Chantaren P, et autres
Publié: (2012)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
par: Bhoomibunchoo C, et autres
Publié: (2017)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
par: Dhirani NA, et autres
Publié: (2017)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
par: I. V. Zlobin, et autres
Publié: (2019)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
par: Dimitrios A Karagiannis, et autres
Publié: (2009)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
par: Miura M, et autres
Publié: (2013)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
par: Arakawa A, et autres
Publié: (2017)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
par: Peng-Yao Lin, et autres
Publié: (2021)

The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes
par: Huajui Wu, et autres
Publié: (2021)

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa
par: Oluleye TS, et autres
Publié: (2013)

Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
par: Joo Young Kim, et autres
Publié: (2021)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
par: Arias L, et autres
Publié: (2016)

Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries
par: Ghoraba HH, et autres
Publié: (2018)

Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
par: Nemoto R, et autres
Publié: (2012)

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy
par: Te-An Wang, et autres
Publié: (2021)

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
par: Kitahashi M, et autres
Publié: (2014)

Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study
par: Daniel Shu Wei Ting, et autres
Publié: (2017)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
par: Callizo J, et autres
Publié: (2019)

Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography
par: Georges Azar, et autres
Publié: (2021)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
par: Korol AR, et autres
Publié: (2017)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
par: Andrzej Grzybowski, et autres
Publié: (2021)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
par: Mario R Romano, et autres
Publié: (2010)

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
par: Yamashita M, et autres
Publié: (2014)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
par: Sakurai M, et autres
Publié: (2014)

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
par: Bhatia D, et autres
Publié: (2021)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
par: Sheng-Chu Chi, et autres
Publié: (2021)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
par: Ki Won Jin, et autres
Publié: (2021)

Thailand as Regional Actor in South-East Asia: Experience of “Soft” Regionalism
par: S. Navapat
Publié: (2018)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
par: Karagiannis DA, et autres
Publié: (2020)

Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography
par: Shang-Te Ma, et autres
Publié: (2021)

Deep learning and ensemble stacking technique for differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration
par: Yu-Bai Chou, et autres
Publié: (2021)

International Trade and Health in Thailand: A Scoping Review
par: Kamonwan Kiewnin, et autres
Publié: (2021)

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
par: Yan Li, et autres
Publié: (2021)

Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
par: Ortiz,Gustavo, et autres
Publié: (2014)